1 Study Coverage

• 1.1 Human Vaccination Product Introduction
• 1.2 Global Human Vaccination Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Human Vaccination Sales in US$ Million for the Year 2017-2028

1.2.2 Global Human Vaccination Sales in Volume for the Year 2017-2028

1.3 United States Human Vaccination Outlook 2017 VS 2022 VS 2028

1.3.1 United States Human Vaccination Sales in US$ Million for the Year 2017-2028

1.3.2 United States Human Vaccination Sales in Volume for the Year 2017-2028

1.4 Human Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4.1 The Market Share of United States Human Vaccination in Global, 2017 VS 2022 VS 2028

1.4.2 The Growth Rate of Human Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.5 Human Vaccination Market Dynamics

1.5.1 Human Vaccination Industry Trends

1.5.2 Human Vaccination Market Drivers

1.5.3 Human Vaccination Market Challenges

1.5.4 Human Vaccination Market Restraints

1.6 Study Objectives

1.7 Years Considered

2 Market by Type

• 2.1 Human Vaccination Market Segment by Type
• 2.1.1 Inactivated Vaccine

2.1.2 Live-attenuated Vaccine

2.1.3 mRNA Vaccine

2.1.4 Conjugate Vaccine

2.1.5 Other

2.2 Global Human Vaccination Market Size by Type

2.2.1 Global Human Vaccination Sales in Value, by Type (2017, 2022 & 2028)

2.2.2 Global Human Vaccination Sales in Volume, by Type (2017, 2022 & 2028)

2.2.3 Global Human Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)

2.3 United States Human Vaccination Market Size by Type

2.3.1 United States Human Vaccination Sales in Value, by Type (2017, 2022 & 2028)

2.3.2 United States Human Vaccination Sales in Volume, by Type (2017, 2022 & 2028)

2.3.3 United States Human Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Human Vaccination Market Segment by Application
• 3.1.1 Government Institution

3.1.2 Private Sector

3.1.3 Other

3.2 Global Human Vaccination Market Size by Application

3.2.1 Global Human Vaccination Sales in Value, by Application (2017, 2022 & 2028)

3.2.2 Global Human Vaccination Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 Global Human Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)

3.3 United States Human Vaccination Market Size by Application

3.3.1 United States Human Vaccination Sales in Value, by Application (2017, 2022 & 2028)

3.3.2 United States Human Vaccination Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 United States Human Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Human Vaccination Competitor Landscape by Company

• 4.1 Global Human Vaccination Market Size by Company
• 4.1.1 Top Global Human Vaccination Manufacturers Ranked by Revenue (2021)

4.1.2 Global Human Vaccination Revenue by Manufacturer (2017-2022)

4.1.3 Global Human Vaccination Sales by Manufacturer (2017-2022)

4.1.4 Global Human Vaccination Price by Manufacturer (2017-2022)

4.2 Global Human Vaccination Concentration Ratio (CR)

4.2.1 Human Vaccination Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Vaccination in 2021

4.2.3 Global Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Human Vaccination Manufacturing Base Distribution, Product Type

4.3.1 Global Human Vaccination Manufacturers, Headquarters and Distribution of Producing Region

4.3.2 Manufacturers Human Vaccination Product Type

4.3.3 Date of International Manufacturers Enter into Human Vaccination Market

4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

4.5 United States Human Vaccination Market Size by Company

4.5.1 Top Human Vaccination Players in United States, Ranked by Revenue (2021)

4.5.2 United States Human Vaccination Revenue by Players (2020, 2021 & 2022)

4.5.3 United States Human Vaccination Sales by Players (2020, 2021 & 2022)

5 Global Human Vaccination Market Size by Region

• 5.1 Global Human Vaccination Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Human Vaccination Market Size in Volume by Region (2017-2028)
• 5.2.1 Global Human Vaccination Sales in Volume by Region: 2017-2022

5.2.2 Global Human Vaccination Sales in Volume Forecast by Region (2023-2028)

5.3 Global Human Vaccination Market Size in Value by Region (2017-2028)

5.3.1 Global Human Vaccination Sales in Value by Region: 2017-2022

5.3.2 Global Human Vaccination Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Human Vaccination Market Size YoY Growth 2017-2028

6.1.2 North America Human Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Human Vaccination Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Human Vaccination Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Human Vaccination Market Size YoY Growth 2017-2028

6.3.2 Europe Human Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Human Vaccination Market Size YoY Growth 2017-2028

6.4.2 Latin America Human Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Human Vaccination Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Human Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 GSK
• 7.1.1 GSK Corporation Information

7.1.2 GSK Description and Business Overview

7.1.3 GSK Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.1.4 GSK Human Vaccination Products Offered

7.1.5 GSK Recent Development

7.2 Merck

7.2.1 Merck Corporation Information

7.2.2 Merck Description and Business Overview

7.2.3 Merck Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.2.4 Merck Human Vaccination Products Offered

7.2.5 Merck Recent Development

7.3 Sanofi

7.3.1 Sanofi Corporation Information

7.3.2 Sanofi Description and Business Overview

7.3.3 Sanofi Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.3.4 Sanofi Human Vaccination Products Offered

7.3.5 Sanofi Recent Development

7.4 Sinovac

7.4.1 Sinovac Corporation Information

7.4.2 Sinovac Description and Business Overview

7.4.3 Sinovac Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.4.4 Sinovac Human Vaccination Products Offered

7.4.5 Sinovac Recent Development

7.5 Zhejiang Pukang

7.5.1 Zhejiang Pukang Corporation Information

7.5.2 Zhejiang Pukang Description and Business Overview

7.5.3 Zhejiang Pukang Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.5.4 Zhejiang Pukang Human Vaccination Products Offered

7.5.5 Zhejiang Pukang Recent Development

7.6 Changchun Institute of Biological

7.6.1 Changchun Institute of Biological Corporation Information

7.6.2 Changchun Institute of Biological Description and Business Overview

7.6.3 Changchun Institute of Biological Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.6.4 Changchun Institute of Biological Human Vaccination Products Offered

7.6.5 Changchun Institute of Biological Recent Development

7.7 KM Biologics

7.7.1 KM Biologics Corporation Information

7.7.2 KM Biologics Description and Business Overview

7.7.3 KM Biologics Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.7.4 KM Biologics Human Vaccination Products Offered

7.7.5 KM Biologics Recent Development

7.8 IMBCAMS

7.8.1 IMBCAMS Corporation Information

7.8.2 IMBCAMS Description and Business Overview

7.8.3 IMBCAMS Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.8.4 IMBCAMS Human Vaccination Products Offered

7.8.5 IMBCAMS Recent Development

7.9 Convac

7.9.1 Convac Corporation Information

7.9.2 Convac Description and Business Overview

7.9.3 Convac Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.9.4 Convac Human Vaccination Products Offered

7.9.5 Convac Recent Development

7.10 NCPC

7.10.1 NCPC Corporation Information

7.10.2 NCPC Description and Business Overview

7.10.3 NCPC Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.10.4 NCPC Human Vaccination Products Offered

7.10.5 NCPC Recent Development

7.11 Bio Kangtai

7.11.1 Bio Kangtai Corporation Information

7.11.2 Bio Kangtai Description and Business Overview

7.11.3 Bio Kangtai Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.11.4 Bio Kangtai Human Vaccination Products Offered

7.11.5 Bio Kangtai Recent Development

7.12 Dynavax

7.12.1 Dynavax Corporation Information

7.12.2 Dynavax Description and Business Overview

7.12.3 Dynavax Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.12.4 Dynavax Products Offered

7.12.5 Dynavax Recent Development

7.13 Hissen

7.13.1 Hissen Corporation Information

7.13.2 Hissen Description and Business Overview

7.13.3 Hissen Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.13.4 Hissen Products Offered

7.13.5 Hissen Recent Development

7.14 KM Biologics

7.14.1 KM Biologics Corporation Information

7.14.2 KM Biologics Description and Business Overview

7.14.3 KM Biologics Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.14.4 KM Biologics Products Offered

7.14.5 KM Biologics Recent Development

7.15 LG Life Sciences

7.15.1 LG Life Sciences Corporation Information

7.15.2 LG Life Sciences Description and Business Overview

7.15.3 LG Life Sciences Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.15.4 LG Life Sciences Products Offered

7.15.5 LG Life Sciences Recent Development

7.16 Serum Institute

7.16.1 Serum Institute Corporation Information

7.16.2 Serum Institute Description and Business Overview

7.16.3 Serum Institute Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.16.4 Serum Institute Products Offered

7.16.5 Serum Institute Recent Development

7.17 Pfizer

7.17.1 Pfizer Corporation Information

7.17.2 Pfizer Description and Business Overview

7.17.3 Pfizer Human Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.17.4 Pfizer Products Offered

7.17.5 Pfizer Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Human Vaccination Industry Chain Analysis
• 8.2 Human Vaccination Key Raw Materials
• 8.2.1 Key Raw Materials

8.2.2 Human Vaccination Distributors

8.3 Human Vaccination Production Mode & Process

8.4 Human Vaccination Sales and Marketing

8.4.1 Human Vaccination Sales Channels

8.4.2 Human Vaccination Distributors

8.5 Human Vaccination Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
• 10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Market Analysis and Insights: Global and United States Human Vaccination Market

This report focuses on global and United States Human Vaccination market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Human Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Inactivated Vaccine accounting for % of the Human Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Government Institution was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Human Vaccination market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Human Vaccination Scope and Market Size

Human Vaccination market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Human Vaccination market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Human Vaccination market is segmented into

Inactivated Vaccine

Live-attenuated Vaccine

mRNA Vaccine

Conjugate Vaccine

Other

Segment by Application, the Human Vaccination market is segmented into

Government Institution

Private Sector

Other

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Human Vaccination Market Share Analysis

Human Vaccination market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Vaccination business, the date to enter into the Human Vaccination market, Human Vaccination product introduction, recent developments, etc.

The major vendors covered:

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

KM Biologics

IMBCAMS

Convac

NCPC

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Pfizer